In-vitro Antiproliferative Activity of Benzopyranone Derivatives in Comparison with Standard Chemotherapeutic Drugs

Authors

Musiliyu A. Musa
John S. Cooperwood
M. O. Faruk Khan, Marshall UniversityFollow
Taufiq Rahman

Document Type

Article

Publication Date

2-2011

Abstract

The cytotoxic activities of five new benzopyranone derivatives containing basic amino side chain are described. Their cytotoxicities against ER(+) MCF-7 and ER(–) MDA-MB-231 human breast cancer cell lines, and Ishikawa human endometrial cell line were determined after 72 h drug exposure employing CellTiter-Glo assay at concentrations ranging from 0.01–1.0 × 105 nM. The antiproliferative activities of these compounds were compared to tamoxifen (TAM), 4-hydroxytamoxifen (4-OHT, active metabolite of tamoxifen), and raloxifene (RAL). In-vitro results indicated that compounds 9, 10, 12, and 13 were more potent than TAM against the human breast cancer cell lines with IC50 < 20 µM. The in-silico structure–activity relationships of these compounds and their binding mode within the estrogen receptor (ER) binding site using AutoDock vina are discussed.

Comments

The version of record is available from the publisher at http://onlinelibrary.wiley.com/doi/10.1002/ardp.201000207/epdf. Copyright © 2011 WILEY-VCH Verlag GmbH & Co. KgaA, Weinheim

doi: 10.1002/ardp.201000207/epdf

Recommended Citation

Musa, M. A., Cooperwood, J. S., Khan, M. O. F. and Rahman, T. (2011), In-vitro Antiproliferative Activity of Benzopyranone Derivatives in Comparison with Standard Chemotherapeutic Drugs. Arch. Pharm. Pharm. Med. Chem., 344: 102–110. doi:10.1002/ardp.201000207